Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin adjunctive therapy in children with partial onset seizures
NL-OMON39878Phase 3Active, not recruiting
- Sponsor
- Pfizer
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in epilepsy (3 arms), sponsored by Pfizer. Primary endpoint: Primary efficacy endpoint. Started Apr 2012; status: active, not recruiting.
02
Drugs
pregabalin
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON39878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39878.